Form 8-K - Current report:
SEC Accession No. 0001193125-24-223695
Filing Date
2024-09-23
Accepted
2024-09-23 16:18:59
Documents
19
Period of Report
2024-09-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d844966d8k.htm   iXBRL 8-K 36554
2 EX-4.1 d844966dex41.htm EX-4.1 319082
3 EX-4.2 d844966dex42.htm EX-4.2 168072
4 EX-4.3 d844966dex43.htm EX-4.3 168099
5 EX-4.4 d844966dex44.htm EX-4.4 168185
6 EX-5.1 d844966dex51.htm EX-5.1 16525
10 GRAPHIC g844966g0921033409606.jpg GRAPHIC 2452
  Complete submission text file 0001193125-24-223695.txt   1194641

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA lh-20240923.xsd EX-101.SCH 2845
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE lh-20240923_lab.xml EX-101.LAB 17236
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lh-20240923_pre.xml EX-101.PRE 10811
21 EXTRACTED XBRL INSTANCE DOCUMENT d844966d8k_htm.xml XML 3487
Mailing Address 358 S MAIN ST BURLINGTON NC 27215
Business Address 358 S MAIN ST BURLINGTON NC 27215 3362291127
LABCORP HOLDINGS INC. (Filer) CIK: 0000920148 (see all company filings)

EIN.: 992588107 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11353 | Film No.: 241316458
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)